Realistic, evidence-based patient recruitment goals are key, Shire

By Gareth Macdonald

- Last updated on GMT

Related tags Patient recruitment Pharmaceutical industry

An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals.

Kim spoke with Outsourcing-pharma.com ahead of his presentation at Patient Recruitment Outsourcing 2011​ next month and suggested that, in terms of patient recruitment, the pharmaceutical industry has not always been good at using data.

He explained that assumptions about patient populations made during protocol development can determine inclusion and exclusion criteria despite the lack of supporting data.

Instead, Kim said that drug companies need to define the benefits of a more evidence based approach, citing the high cost of protocol amendments as a useful metric. Then, he continued, they need to adopt a create approach to data collection and analysis.

CRO role and need for investment

Kim also suggested that contract research organisations (CROs) can play an important role in the protocol development process if they can successfully move from the traditional survey-based approach to feasibility to a more data-focused model.

They [CROs] are the builder to the [pharma] architect and the architect needs to know how realistic its designs are​.”

One of the hurdles CROs face in introducing this sort of initiative is that a data-focused approach requires investment which, according to Kim, contractors are sometimes reluctant to do unless such spending generated revenue.

Kim will be covering this and various other aspects of patient recruitment during his presentation at Patient recruitment Outsourcing 2011​ in September. Sign up and attend this Outsourcing-pharma.com event here​.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars